These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 11337321)

  • 1. Combined intraarterial carboplatin, intraarterial etoposide phosphate, and IV Cytoxan chemotherapy for progressive optic-hypothalamic gliomas in young children.
    Osztie E; Várallyay P; Doolittle ND; Lacy C; Jones G; Nickolson HS; Neuwelt EA
    AJNR Am J Neuroradiol; 2001 May; 22(5):818-23. PubMed ID: 11337321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin/vincristine chemotherapy for hypothalamic/visual pathway astrocytomas in young children.
    Kato T; Sawamura Y; Tada M; Ikeda J; Ishii N; Abe H
    J Neurooncol; 1998 May; 37(3):263-70. PubMed ID: 9524084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-arterial carboplatin and intravenous etoposide for the treatment of recurrent and progressive non-GBM gliomas.
    Newton HB; Slivka MA; Stevens CL; Bourekas EC; Christoforidis GA; Baujan MA; Chakeres DW
    J Neurooncol; 2002 Jan; 56(1):79-86. PubMed ID: 11949830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose cyclophosphamide, carboplatin, and etoposide with autologous stem cell rescue in patients with breast cancer.
    deMagalhaes-Silverman M; Rybka WB; Lembersky B; Bloom EJ; Lister J; Pincus SM; Voloshin M; Wilson J; Ball ED
    Am J Clin Oncol; 1996 Apr; 19(2):169-73. PubMed ID: 8610643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
    Gnekow AK; Kortmann RD; Pietsch T; Emser A
    Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visual improvement despite radiologically stable disease after treatment with carboplatin in children with progressive low-grade optic/thalamic gliomas.
    Mitchell AE; Elder JE; Mackey DA; Waters KD; Ashley DM
    J Pediatr Hematol Oncol; 2001 Dec; 23(9):572-7. PubMed ID: 11902299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination chemotherapy using carboplatin (JM-8) and etoposide (JET therapy) for recurrent malignant gliomas: a phase II study.
    Watanabe K; Kanaya H; Fujiyama Y; Kim P
    Acta Neurochir (Wien); 2002 Dec; 144(12):1265-70; discussion 1270. PubMed ID: 12478337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osmotic blood-brain barrier disruption chemotherapy for diffuse pontine gliomas.
    Hall WA; Doolittle ND; Daman M; Bruns PK; Muldoon L; Fortin D; Neuwelt EA
    J Neurooncol; 2006 May; 77(3):279-84. PubMed ID: 16314949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Management of chiasmatic-hypothalamic gliomas in children: report of nine pediatric cases].
    Akiyama H; Nakamizo S; Kawamura A; Nagashima T; Takeda H; Hasegawa D; Kosaka Y; Yoshida M
    No Shinkei Geka; 2007 Nov; 35(11):1079-85. PubMed ID: 18044225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optic pathway hypothalamic gliomas in children under three years of age: the role of chemotherapy.
    Silva MM; Goldman S; Keating G; Marymont MA; Kalapurakal J; Tomita T
    Pediatr Neurosurg; 2000 Sep; 33(3):151-8. PubMed ID: 11096362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination chemotherapy with cisplatin, carboplatin, and etoposide in advanced malignancy: a phase I trial.
    Rajkumar SV; Frytak S; Rubin J; Camoriano JK; Fitch TR
    Am J Clin Oncol; 1997 Oct; 20(5):500-4. PubMed ID: 9345336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second-line chemotherapy with the association of liposomal daunorubicin, carboplatin and etoposide in children with recurrent malignant brain tumors.
    Fiorillo A; Maggi G; Greco N; Migliorati R; D'Amico A; De Caro MD; Sabbatino MS; Buffardi F
    J Neurooncol; 2004 Jan; 66(1-2):179-85. PubMed ID: 15015784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery.
    Dahlborg SA; Petrillo A; Crossen JR; Roman-Goldstein S; Doolittle ND; Fuller KH; Neuwelt EA
    Cancer J Sci Am; 1998; 4(2):110-24. PubMed ID: 9532413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy with cisplatin and vincristine for optic pathway/hypothalamic astrocytoma in young children.
    Sawamura Y; Kamoshima Y; Kato T; Tajima T; Tsubaki J
    Jpn J Clin Oncol; 2009 May; 39(5):277-83. PubMed ID: 19224939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy for progressive pilocytic astrocytomas in the chiasmo-hypothalamic regions.
    Nishio S; Morioka T; Takeshita I; Shono T; Inamura T; Fujiwara S; Fukui M
    Clin Neurol Neurosurg; 1995 Nov; 97(4):300-6. PubMed ID: 8599896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of chiasmal and hypothalamic gliomas of infancy and childhood with chemotherapy.
    Petronio J; Edwards MS; Prados M; Freyberger S; Rabbitt J; Silver P; Levin VA
    J Neurosurg; 1991 May; 74(5):701-8. PubMed ID: 1901597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temozolomide and oral VP-16 for children and young adults with recurrent or treatment-induced malignant gliomas.
    Korones DN; Smith A; Foreman N; Bouffet E
    Pediatr Blood Cancer; 2006 Jul; 47(1):37-41. PubMed ID: 16047359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-arterial cisplatin plus oral etoposide for the treatment of recurrent malignant glioma: a phase II study.
    Ashby LS; Shapiro WR
    J Neurooncol; 2001 Jan; 51(1):67-86. PubMed ID: 11349883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractionated cyclophosphamide and etoposide for children with advanced or refractory solid tumors: a phase II window study.
    Mantadakis E; Herrera L; Leavey PJ; Bash RO; Winick NJ; Kamen BA
    J Clin Oncol; 2000 Jul; 18(13):2576-81. PubMed ID: 10893289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.